Cargando…

The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism

Manipulation of metabolic pathways in hematological cancers has therapeutic potential. Here, we determined the molecular mechanism of action of the metabolic modulator dichloroacetate (DCA) in leukemic cells. We found that DCA induces the AMP-activated protein kinase (AMPK)/p53 pathway with increase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allende-Vega, Nerea, Krzywinska, Ewelina, Orecchioni, Stefania, Lopez-Royuela, Nuria, Reggiani, Francesca, Talarico, Giovanna, Rossi, Jean-François, Rossignol, Rodrigue, Hicheri, Yosr, Cartron, Guillaume, Bertolini, Francesco, Villalba, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662487/ https://www.ncbi.nlm.nih.gov/pubmed/26231043

Ejemplares similares

Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers
por: Krzywinska, Ewelina, et al.
Publicado: (2015)

Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors
por: Sanchez-Martinez, Diego, et al.
Publicado: (2018)

Dissecting the NK Cell Population in Hematological Cancers Confirms the Presence of Tumor Cells and Their Impact on NK Population Function
por: Vo, Dang-Nghiem, et al.
Publicado: (2020)

CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity
por: Krzywinska, Ewelina, et al.
Publicado: (2016)

Changes in metabolism affect expression of ABC transporters through ERK5 and depending on p53 status
por: Belkahla, Sana, et al.
Publicado: (2017)

Human Leukemic Cells performing Oxidative Phosphorylation (OXPHOS) Generate an Antioxidant Response Independently of Reactive Oxygen species (ROS) Production
por: Khan, Abrar Ul Haq, et al.
Publicado: (2015)

Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cells
por: Allende-Vega, Nerea, et al.
Publicado: (2019)

The metabolism of cells regulates their sensitivity to NK cells depending on p53 status
por: Belkahla, Sana, et al.
Publicado: (2022)

Mitochondrial Complex I activity signals antioxidant response through ERK5
por: Khan, Abrar Ul Haq, et al.
Publicado: (2018)

Ubiquitin and SUMO conjugation as biomarkers of acute myeloid leukemias response to chemotherapies
por: Gâtel, Pierre, et al.
Publicado: (2020)

Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma
por: Orecchioni, Stefania, et al.
Publicado: (2018)

Metformin sensitizes leukemic cells to cytotoxic lymphocytes by increasing expression of intercellular adhesion molecule-1 (ICAM-1)
por: Allende-Vega, Nerea, et al.
Publicado: (2022)

The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 Pathway
por: Khan, Abrar Ul Haq, et al.
Publicado: (2017)

Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells
por: Talarico, Giovanna, et al.
Publicado: (2016)

Erratum: The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia
por: Allegretti, Matteo, et al.
Publicado: (2016)

The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia
por: Allegretti, Matteo, et al.
Publicado: (2015)

Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells
por: Salvestrini, Valentina, et al.
Publicado: (2016)

Vinorelbine and Intermittent Cyclophosphamide Sensitize an Aggressive Myc-Driven B-Cell Lymphoma to Anti-PD-1 by an Immunological Memory Effective against Tumor Re-Challenge
por: Orecchioni, Stefania, et al.
Publicado: (2023)

Venetoclax in Acute Myeloid Leukemia: Molecular Basis, Evidences for Preclinical and Clinical Efficacy and Strategies to Target Resistance
por: Garciaz, Sylvain, et al.
Publicado: (2021)

Cytomegalovirus Infection With Retinitis After Brentuximab Vedotin Treatment for CD30(+) Lymphoma
por: Tudesq, Jean-Jacques, et al.
Publicado: (2017)

Hypoxia, Metabolism and Immune Cell Function
por: Krzywinska, Ewelina, et al.
Publicado: (2018)

Lung Cancer Onset in Wild Type Mice Following Bone Marrow Reconstitution with kras(v12) Cells
por: Belloni, Elena, et al.
Publicado: (2015)

EZH2 in normal hematopoiesis and hematological malignancies
por: Herviou, Laurie, et al.
Publicado: (2015)

High levels of MDM2 are not correlated with the presence of wild-type p53 in human malignant mesothelioma cell lines.
por: Ungar, S., et al.
Publicado: (1996)

GM-CSF promotes a supportive adipose and lung microenvironment in metastatic breast cancer
por: Reggiani, Francesca, et al.
Publicado: (2017)

The Presence of Mycobacterium leprae in Wild Rodents
por: de Lima, Maxwell Furtado, et al.
Publicado: (2022)

Targeting p53 by small molecules in hematological malignancies
por: Saha, Manujendra N, et al.
Publicado: (2013)

A “two-hit” (chemo)therapy to improve checkpoint inhibition in cancer
por: Falvo, Paolo, et al.
Publicado: (2021)

Can Automated Hematology Analyzers Predict the Presence of a Genetic Hemoglobinopathy? An Analysis of Hematological Biomarkers in Cambodian Women
por: Pei, Lulu X., et al.
Publicado: (2021)

Cellular and Molecular Players in the Interplay between Adipose Tissue and Breast Cancer
por: Reggiani, Francesca, et al.
Publicado: (2021)

The Presence of an Enzootic of Rickettsial Infection in Wild Rats of Calcutta
por: Goyal, R. K.
Publicado: (1941)

Functional Diversity of p53 in Human and Wild Animals
por: Li, Yi, et al.
Publicado: (2019)

Increased Glyphosate-Induced Gene Expression in the Shikimate Pathway Is Abolished in the Presence of Aromatic Amino Acids and Mimicked by Shikimate
por: Zulet-González, Ainhoa, et al.
Publicado: (2020)

Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis
por: Kim, Rathana, et al.
Publicado: (2023)

TP53 Expression and Mutational Analysis in Hematological Malignancy in Jeddah, Saudi Arabia
por: Alkhatabi, Heba, et al.
Publicado: (2022)

Presence of Vaccine-Derived Newcastle Disease Viruses in Wild Birds
por: Ayala, Andrea J., et al.
Publicado: (2016)

Loss of Geminin induces rereplication in the presence of functional p53
por: Melixetian, Marina, et al.
Publicado: (2004)

Expression of wild-type and mutated TP53 in breast carcinomas
por: Baumbusch, LO, et al.
Publicado: (2005)

CRISPR screens are feasible in TP53 wild‐type cells
por: Brown, Kevin R, et al.
Publicado: (2019)

Genomic Characterization of TP53–Wild-Type Esophageal Carcinoma()
por: Quaas, Alexander, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rr5sjnvtku0h6f2oghrurvb75h